Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04170231 · ClinicalTrials.gov registry record
Bleeding in Critically Ill Children With Underlying Oncologic Diagnoses
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 93
- Enrollment target
NCT04170231: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT04170231 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 93 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04170231 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 93 participants
- Enrollment target
Study Summary
"Bleeding in Critically Ill Children with Underlying Oncologic Diagnoses ," will be a prospective observational cohort study looking at the epidemiology of bleeding in the pediatric ICU population at MSK.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2019-11-18 |
| Est. Completion | 2023-10-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04170231
The ClinicalTrials.gov registry entry for NCT04170231 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04170231 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04170231 about?
NCT04170231 is a clinical study titled "Bleeding in Critically Ill Children With Underlying Oncologic Diagnoses". "Bleeding in Critically Ill Children with Underlying Oncologic Diagnoses ," will be a prospective observational cohort study looking at the epidemiology of bleeding in the pediatric ICU population at MSK.
What is the current status of trial NCT04170231?
This trial is currently completed. The enrollment target is 93 participants. The study started on 2019-11-18. Estimated completion is 2023-10-18.
Who is sponsoring clinical trial NCT04170231?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.